The protein product of the abnormal Bcr-Abl fusion gene is the oncoprotein BCR-ABL, which is expressed in CML and Ph+ ALL [2, 3]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.